Bailer, Susanne Prof. Dr. sc. nat.

Head of Innovation Field Virus-based Technologies

Susanne Bailer studied biology at the Universities of Ulm and Freiburg. In 1990 she obtained her doctorate, after which she continued her work in the department of Biochemistry and Molecular Biology at Saarland University, Homburg, in 2005. Through the Ludwig-Maximilians-University Munich, she joined Fraunhofer IGB in Stuttgart in 2012 as the group manager of “Infection Biology and Array Technology”. Since 2019 she has been leading the innovation field “Virus-based Technologies”.

In 2013, Bailer started working as a private lecturer in Stuttgart and took over the lead of the Biological-Medical Interfaces group at the Institute of Interfacial Process Engineering and Plasma Technology IGVP. In 2017, she was appointed as an adjunct professor at the University of Stuttgart.

Together with her university research group, Susanne Bailer studies elementary mechanisms of the infection biology of herpes viruses. Thereby, her accumulated discoveries enable a seamless transition to the application-oriented research at Fraunhofer IGB.

Here, the scientist’s research focuses on the development of innovative virus-based therapies and technologies, and on technologies for diagnosing infectious agents.

Additionally, Bailer leads the activities in the Health area of the Biointelligence Competence Center.

    • Engineering of therapeutic viruses
    • Oncolytic viruses
    • Viral vectors (cell and gene therapy)
    • Herpesviruses and their infection biology
    • Phage technology
    • Virus-like particles
    • PCR and array technologies
    • German Academic Exchange Service (DAAD), reviewer
    • Head of the Health Alliance area of the Biointelligence Competence Center
  • Project title Project title long Funding source Period
    Personalized fingerprint  Personalized fingerprint of liquids for the detection of germs Ministerium für Wissenschaft, Forschung und Kunst of the State of Baden-Württemberg / High Performance Center Mass Personalization March 2021 – December 2021
    Healthy Air Initiative Advisory center on ventilation concepts and air cleaning technologies for small and medium-sized companies 
    WM February 2021 – December 2021
    STD-Array Identification of pathogens of sexually transmitted diseases with highly parallel diagnostics using DNA microarray Industry  
    Vari-VLP Development of a universal modular system for the production of virus-like particles for pharmaceutical application Fraunhofer  
    FutureProteins Coupled agricultural systems for resilient and resource-efficient production of high-quality food proteins BMBF January 2021 – December 2024
    FhVT Fraunhofer Vaccine Technologies Technological development of vaccine production and packaging processes as well as analytical methods for their characterization Fraunhofer January 2021 – December 2021
    AVATOR Anti-Virus-Aersol: Testing, Operation, Reduction with project "Virus Grill" Fraunhofer October 2020 – September 2021
    CoroVacc Development of a SARS-CoV-2 specific vaccine based on attenuated carrier viruses Fraunhofer July 2020 – December 2021
    ViProTeFa Development and establishment of a virus protection test facility Fraunhofer July 2020 – June 2021
    Development of a lateral flow assay for the nucleic acid-based molecular detection of pathogens Development of a lateral flow assay for the nucleic acid-based molecular detection of pathogens High‑Performance Center for Mass Personalization January 2019 – December 2019
    Kari-EX Using phages against caries Fraunhofer October 2018 – September 2019
    TheraVision
    Platform technology for the development, production and testing of oncolytic viruses Fraunhofer April 2017 – March 2020
    eVaccine A novel inactivation method for the production of a cost-effective poliovirus vaccine Bill-und-Melinda-Gates-Stiftung September 2016 – August 2018
    DigiAutoPharma